PUSH: Helping People with HIV and Substance Use
Part of Immune system & allergy, Infections, Mental health clinical trials.
This study tests if a program that encourages positive activities (behavioral activation) can help people with HIV or on PrEP who also use substances improve their health. It focuses on those receiving long-acting injectable medications for HIV prevention or treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older
- You have HIV (and are on treatment) or you are HIV negative (and eligible for PrEP)
- You are using or willing to use a long-acting injectable medication (Cabotegravir/Rilpivirine) for HIV prevention or treatment
- You have moderate substance use (like cocaine, amphetamines, opioids, alcohol) — based on a screening questionnaire
- You are not pregnant or breastfeeding
- You do not have medical conditions that prevent using these injectable medications
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how to better support young men living with or at risk for HIV while also addressing substance use. You'll work with a care team that helps you stay healthy and connected to services.
This study looks at using social connections to help people who inject drugs get HIV prevention and substance use support. The trial tests a program in Los Angeles that works with friends or peers to encourage PrEP (HIV prevention pills) and addiction treatment.
This study tests an alcohol- and sexual-health program to help reduce HIV risk in men who recently had condomless sex and drink heavily. It may help you by offering structured support around drinking and HIV prevention (PrEP).
This study helps young adults who have had contact with the criminal legal system access HIV prevention services and support for substance use. Researchers will connect you with health resources and track whether an app-based service helps you stay healthy and engaged with care.
This study tests a program to help Black and Hispanic women with substance use disorders take PrEP consistently to prevent HIV. The goal is to see if talking with a health coach can improve PrEP use and reduce HIV risk.
This study tests whether a combination of buprenorphine (a medication for opioid addiction) and PrEP (a daily pill to prevent HIV) can help people who are leaving jail or prison stay healthy. It aims to reduce both opioid relapse and HIV risk during the transition back to the community.
Hear when a new HIV Infections trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.